AZP 531 is an analogue of unacyclated ghrelin potentially for the treatment of Prader-Willi syndrome. References: Allas S, Delale T, Ngo N, Julien M, Sahakian P, Ritter J, Abribat T, van der Lely AJ. Safety, tolerability, pharmacokinetics and pharmacodynamics of AZP-531, a first-in-class analogue of unacylated ghrelin, in healthy and overweight/obese subjects and subjects with type 2 diabetes. Diabetes Obes Metab. 2016 Sep;18(9):868-74. doi: 10.1111/dom.12675. PubMed PMID: 27063928.

纯度：≥98%

CAS：1088543-62-7